Insider · CIK 0001214133

SCHELLER RICHARD H

Reports to the SEC for 8 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001214133

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	134,899
2026-06-17	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2026-06-08	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2026-06-01	ALECAlector, Inc.A Award	Director	AAward	+10.8K sh	—	—	106,199
2025-09-22	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2025-09-15	MAZEMaze Therapeutics, Inc.S Sale	Director	SSale	−20.7K sh	$22.37	−$464K	0
2025-06-11	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	95,366
2025-06-11	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2025-05-02	ALECAlector, Inc.A Award	Director	AAward	+15.8K sh	—	—	66,666
2024-08-26	MEHCQChrome Holding Co.A Award	Director	AAward	+658K sh	—	—	895,961
2024-08-22	ALECAlector, Inc.S Sale	Director	SSale	−44.3K sh	$5.16	−$228K	35,000
2024-08-02	ALECAlector, Inc.A Award	Director	AAward	+15.8K sh	—	—	50,833
2024-06-12	ALECAlector, Inc.A Award	Director	AAward	+35K sh	—	—	79,250
2023-09-06	MEHCQChrome Holding Co.A Award	Director	AAward	+165K sh	—	—	237,476
2023-08-09	DICE Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,427 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,357 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,138 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,261 sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.6K sh	—	—	0
2023-08-09	DICE Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.3K sh	—	—	0
2023-07-15	ALECAlector, Inc.A Award	Director	AAward	+8,541 sh	—	—	44,250
2023-06-14	ALECAlector, Inc.A Award	Director	AAward	+26.3K sh	—	—	35,709
2023-06-14	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,360
2023-05-05	DICE Therapeutics, Inc.S Sale	Director	SSale	−84.1K sh	$38.51	−$3.24M	8,427
2023-02-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,196 sh	—	—	55,126
2023-02-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director	FTax Payment	−1,304 sh	$12.64	−$16.5K	53,822
2023-02-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,196 sh	—	—	12,783
2022-11-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,196 sh	—	—	53,036
2022-11-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director	FTax Payment	−1,106 sh	$9.64	−$10.7K	51,930
2022-11-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,196 sh	—	—	15,979
2022-11-11	MEHCQChrome Holding Co.S Sale	Director	SSale	−18.4K sh	$3.24	−$59.7K	72,388
2022-09-06	MEHCQChrome Holding Co.A Award	Director	AAward	+14.6K sh	—	—	90,809
2022-08-25	MEHCQChrome Holding Co.A Award	Director	AAward	+57.8K sh	—	—	76,176
2022-08-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,196 sh	—	—	50,941
2022-08-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director	FTax Payment	−1,101 sh	$11.08	−$12.2K	49,840
2022-08-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,196 sh	—	—	19,175
2022-06-22	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,921
2022-06-16	ALECAlector, Inc.A Award	Director	AAward	+9,459 sh	—	—	9,459
2022-06-16	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,918
2022-06-07	DICE Therapeutics, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+31.3K sh	—	—	31,250
2022-05-16	BBIOBridgeBio Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,195 sh	—	—	49,055
2022-05-16	BBIOBridgeBio Pharma, Inc.F Tax Payment	Director	FTax Payment	−1,310 sh	$6.74	−$8,829.4	47,745
2022-05-16	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,195 sh	—	—	22,371
2022-02-28	BBIOBridgeBio Pharma, Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.6K sh	—	—	25,566
2021-12-02	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+28.9K sh	—	—	28,881
2021-12-02	BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,685
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+4,357 sh	—	—	4,357
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,138 sh	—	—	9,138
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,261 sh	—	—	8,261
2021-09-14	DICE Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500

Recent filings

Accepted (ET)
Jun 174
SCHELLER RICHARD H0001193125-26-274128
SEC(opens sec.gov)
Jun 104
SCHELLER RICHARD H0001214133-26-000002
SEC(opens sec.gov)
Jun 34
SCHELLER RICHARD H0001193125-26-255990
SEC(opens sec.gov)
Sep 244
SCHELLER RICHARD H0001214133-25-000007
SEC(opens sec.gov)
Sep 164
SCHELLER RICHARD H0001214133-25-000005
SEC(opens sec.gov)
Jun 124
SCHELLER RICHARD H0000950170-25-085617
SEC(opens sec.gov)
May 24
SCHELLER RICHARD H0000950170-25-062995
SEC(opens sec.gov)
Oct 104
SCHELLER RICHARD H0000950170-24-114050
SEC(opens sec.gov)
Aug 284
SCHELLER RICHARD H0001628280-24-038683
SEC(opens sec.gov)
Aug 234
SCHELLER RICHARD H0000950170-24-100168
SEC(opens sec.gov)
Jun 124
SCHELLER RICHARD H0000950170-24-072515
SEC(opens sec.gov)
Feb 144
SCHELLER RICHARD H0000950170-24-015412
SEC(opens sec.gov)
Sep 84
SCHELLER RICHARD H0001209191-23-048806
SEC(opens sec.gov)
Aug 94
SCHELLER RICHARD H0001209191-23-045175
SEC(opens sec.gov)

Companies

Address

C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600

SOUTH SAN FRANCISCO, CA, 94080